Maryse Dupouy
Overview
Explore the profile of Maryse Dupouy including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
102
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Etienne G, Dupouy M, Costaglioli P, Chollet C, Lagarde V, Pasquet J, et al.
Dis Markers
. 2011 Jul;
30(5):221-7.
PMID: 21734341
Objective: Imatinib mesylate is a tyrosine kinase inhibitor used as first line treatment in chronic myeloid leukaemia. Despite a remarkable effectiveness, treatment failure cases have been reported in 20 percent...
2.
Pocaly M, Lagarde V, Etienne G, Dupouy M, Lapaillerie D, Claverol S, et al.
Proteomics
. 2008 Jun;
8(12):2394-406.
PMID: 18563733
Understanding the molecular basis of resistance to imatinib, a tyrosine kinase inhibitor used as front-line therapy in chronic myeloid leukemia, remains a challenge for successful treatment. In an attempt to...
3.
Solanilla A, Pasquet J, Viallard J, Contin C, Grosset C, Dechanet-Merville J, et al.
Blood
. 2004 Jun;
105(1):215-8.
PMID: 15191945
CD40-ligand (CD154) is expressed on activated CD4+ T lymphocytes and is essential for the T cell-dependent activation of B lymphocytes. CD154 is also expressed at the activated platelet surface. In...
4.
Solanilla A, Grosset C, Duchez P, Legembre P, Pitard V, Dupouy M, et al.
Br J Haematol
. 2003 Mar;
120(5):782-6.
PMID: 12614209
The adhesion of haematopoietic progenitor cells (HPC) to the bone marrow microenvironment is a process regulated by cytokines. In this study, we have shown that flt3-ligand (FL), a growth factor...
5.
Ferry-Dumazet H, Garnier O, Mamani-Matsuda M, Vercauteren J, Belloc F, Billiard C, et al.
Carcinogenesis
. 2002 Aug;
23(8):1327-33.
PMID: 12151351
It is often postulated that trans-3,4',5-trihydroxystilbene (resveratrol, RES) exhibits cell growth regulatory and chemopreventive activities. However, mechanisms by which this polyphenol inhibits tumor cell growth, and its therapeutic potential are...